In the rush to find better immune protections against the Delta variant of COVID-19, China’s medical products regulator has signed off on trials combining the country’s indigenous SinoVac vaccine with a new vaccine by the US-based company Inovio. SinoVac has also reported trials on a third shot show substantial immune benefits.
from Sputnik News - World News, Breaking News & Top Stories https://ift.tt/2VN8Yr9
Thursday, August 12, 2021
China’s COVID-19 Outbreak Hits Ningbo, Shuttering World’s Largest Cargo Terminal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment